There is quite a bit of evidence that statins lower the risk for certain cancers. They may also synergize with some cancer treatments.

MeMeMe trial: metformin cut diabetes 80-92% in metabolic syndrome; Med diet did not
In 1,442 people with metabolic syndrome followed about 3 years, 1,700 mg/day metformin prevented type 2 diabetes, which fully explained the difference in major noncommunicable diseases. The Mediterranean diet intervention did not. Gokhan notes no heart disease or cancer prevention from metformin either.



